tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Lyanne Harrison, 3 are a SELL (30%), 1 are a HOLD (10%), 6 are a BUY (60%).
Analyst Lyanne Harrison, currently employed at BAML, carries an average stock price target met ratio of 38.89% that have a potential upside of 16.92% achieved within 83 days.
Lyanne Harrison’s has documented 20 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 26-Sep-2024.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 8/3/2020. The price target of $180 was fulfilled within 3 days with a profit of $14.08 (7.25%) receiving and performance score of 24.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 months 9 days ago
(31-Jan-2025)
11/11 (100%)
$-7.67 (-3.15%)
212
Buy
$286
$80.83 (39.40%)
2 months 9 days ago
(31-Jan-2025)
14/17 (82.35%)
$50.35 (21.37%)
310
Hold
$260
$54.83 (26.72%)
$252
2 months 9 days ago
(31-Jan-2025)
1/2 (50%)
$24.35 (10.33%)
17
Hold
$250
$44.83 (21.85%)
$225
5 months 15 days ago
(25-Oct-2024)
5/5 (100%)
$-4.95 (-1.94%)
30
Buy
$250
$44.83 (21.85%)
$215
6 months 10 days ago
(30-Sep-2024)
11/11 (100%)
$6.95 (2.86%)
115
What Year was the first public recommendation made by Lyanne Harrison?
